Purchase Order 19GE5025P0103

Award Date 8/29/25
Potential Completion Date 11/30/25
Potential Value $174K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Office of Acquisition Management
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Thailand
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Economy Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order awarded by the Defense Health Agency, a component of the U.S. Department of Defense, to Bio-Active Company LIMITED, a for-profit limited liability company located in Thailand. The $112,739.29 contract is for the purchase of an Illumina MiSeq genetic sequencing system, including reagents and associated components. This award is not associated with a larger contract vehicle, and no small business set-aside provisions were used. Bio-Active Company LIMITED...
This firm fixed price purchase order was awarded to Bio-Active Company LIMITED, a for-profit limited liability company, to provide Illumina reagents on behalf of the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Bangkok, Thailand. The $27,544.10 contract was issued by the U.S. Department of the Army and has a period of performance ending on September 30, 2024. Bio-Active Company LIMITED has a history of delivering genetic sequencing systems, reagents, and testing materials to...
This is a firm fixed-price purchase order awarded by the U.S. Department of the Army to Bio-Active Company LIMITED, a for-profit limited liability company based in Thailand. The contract is for the procurement of Illumina sequencing platforms, including MiSeq and NextSeq systems, to be used for DNA and RNA sequencing of clinical, environmental, and vector-borne disease samples. The award has a ceiling value of $223,391.17 and an ultimate completion date of September 7, 2026. Bio-Active Company...
This is a firm fixed price purchase order awarded by the U.S. Department of Defense's Bureau of Medicine and Surgery (BUMED) to Bio-Active Company Limited, a for-profit limited liability company based in Thailand. The contract, valued at $81,605.50, is for preventive maintenance services on an Illumina MiSeq genetic sequencing system located at the U.S. Naval Medical Research Unit-2 (NAMRU-2) facility in Cambodia. The contract was competitively awarded and does not have a set-aside...
This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Bio-Active Company LIMITED, a for-profit limited liability company based in Thailand. The $102,468 contract is for preventive maintenance services on an Illumina MiSeq genetic sequencing system operated by the Naval Medical Research Unit 2 (NAMRU-2) laboratory in Cambodia. The contract has a completion date of March 7, 2020 and was awarded on March 3, 2017. No set-aside provisions were...
The Defense Intelligence Agency awarded a firm fixed price purchase order for $29,116 to Bio-Active Company LIMITED to provide maintenance support for one Illumina MiSeq next generation sequencing system located in Thailand. The order was issued against a blanket purchase agreement held by Bio-Active Company LIMITED to provide sequencing services and instrument sustainment to multiple U.S. agencies in Thailand, including the Department of Defense, Army Medical Command, and Centers for Disease...
This is a firm fixed price contract awarded by the Office of the Secretary of Defense to Bio-Active Company LIMITED, a for-profit limited liability company, to provide maintenance and emergency services for an Illumina MiSeq genetic sequencing instrument located in Thailand. The contract, valued at $29,088.00, is a call against a pre-existing Blanket Purchase Agreement to support infectious disease monitoring and research efforts by various U.S. government agencies, including the Centers for...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of the Army to Bio-Active Company LIMITED, a for-profit limited liability company based in Thailand. The contract, valued at $42,645.25, provides annual maintenance services for laboratory equipment on behalf of the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Thailand. The contract has an ultimate completion date of November 15, 2026. Bio-Active Company LIMITED is a vendor that...
This is a firm fixed price contract awarded by the Office of Intergovernmental and External Affairs, a civilian agency, to Bio-Active Company LIMITED, a for-profit limited liability company, to provide services on the Illumina MiSeq genetic sequencing system. The contract has a ceiling value of $27,212.02 and a period of performance through August 31, 2025. This is a call order issued against a previously established Blanket Purchase Agreement held by Bio-Active Company LIMITED to provide...
This is a firm fixed price blanket purchase agreement (BPA) call awarded by the Department of the Army to Bio-Active Company LIMITED, a for-profit limited liability company, to provide annual maintenance services for laboratory equipment on behalf of the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Thailand. The contract has a ceiling value of $38,595.47 and a period of performance through November 15, 2025. Bio-Active Company LIMITED has a history of providing biomedical...

This is a firm fixed-price purchase order contract awarded by the Defense Health Agency, a defense agency, to Bio-Active Company LIMITED, a for-profit limited liability company based in Thailand. The contract is for the acquisition of MISEQI100PLUS systems on behalf of the Armed Forces Research Institute of Medical Sciences (AFRIMS) Thailand. The contract has a ceiling value of $174,099.88 and an ultimate completion date of November 30, 2025. No small business set-aside was used for this award. Bio-Active Company LIMITED is a provider of genetic sequencing systems, reagents, and testing materials, with a focus on supporting infectious disease monitoring and research programs for various U.S. government health and defense organizations. The company holds a significant Blanket Purchase Agreement (BPA) with the U.S. Department of Defense's Medical Command (MEDCOM) for the maintenance, emergency, and operational services of Illumina MiSeq genetic sequencing systems, which enables it to support ongoing infectious disease surveillance activities in Thailand.

Generated 10/1/25, 10:12 AM